Tetraphase Pharmaceuticals Inc (TTPH) Inventory Turnover Ratio, from first quarter 2020 to first quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Tetraphase Pharmaceuticals Inc  (NASDAQ: TTPH)
 

Tetraphase Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Tetraphase Pharmaceuticals Inc inventory turnover ratio, the Tetraphase Pharmaceuticals Inc's ability to sell and replace its inventory in the first quarter 2020, sequentially increased to 2 in the first quarter 2020, a new company high. Average inventory processing period, for the Tetraphase Pharmaceuticals Inc in Mar 31 2020 quarter, has decreased to 183 days, compare to 317 days, in the Dec 31 2019 quarter.

Within Healthcare sector 260 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1716 in the fourth quarter 2019, to 1718.

TTPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Tetraphase Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TTPH Inventory Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Inventory Growth -66.44 % 113.24 % - - -
Y / Y Cost of Sales Growth 729.27 % 926.15 % -23.37 % -97.35 % -91.33 %
Inventory Turnover Ratio (TTM) 2 1.15 0.7 1.16 16.83
TTPH's Total Ranking # 1718 # 1716 # 1716 # 1718 # 0
Average inventory processing period 183 317 523 316 22
Seq. Inventory Growth -50.6 % -34.47 % -17.88 % 26.24 % 213.9 %
Seq. Cost of Sales Growth 1.95 % 51.25 % 187.3 % 87.2 % 26.15 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 261
Overall Market # 1718

Inventory Turnover Ratio Statistics
High Average Low
2 1.28 0.7
(Mar 31 2020)   (Sep 30 2019)



TTPH Company Profile >> Back to TTPH Efficiency Comparisons >> Compare TTPH Inventory Turnover Ratio to its Competitors

Financial Statements
Tetraphase Pharmaceuticals Inc's Inventories $ 1 Millions Visit TTPH's Balance sheet
Tetraphase Pharmaceuticals Inc's Cost of Revenues TTM $ 4 Millions Visit TTPH's Income Statement
What are TTPH's Sales? Visit TTPH's Sales by Segment

Other Inventory Turnover Ratios
Tetraphase Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TTPH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TTPH's Competitors
Inventory Turnover Ratio for TTPH's Suppliers
Inventory Turnover Ratio for TTPH's Customers

You may also want to know
TTPH's Sales Growth Rates TTPH's Pe Price to earnings ratio TTPH's Receivables Turnover Ratio TTPH's Stock Quote
TTPH's Net Income Growth Rates TTPH's Ps Price to Sales ratio TTPH's Sales per Employee TTPH's Asset Turnover Ratio
TTPH's Net Margin TTPH's Pb Price to Book ratio TTPH's Financial Strength Ratios TTPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2020 Inventories at quarter ending Mar 31 2020
Healthlynked Corp  13.55 $ 1.218  Millions$ 0  Millions
Viemed Healthcare Inc   13.52 $ 27.462  Millions$ 2  Millions
Star Equity Holdings Inc   12.73 $ 88.086  Millions$ 7  Millions
Incyte Corporation  12.12 $ 118.980  Millions$ 10  Millions
Puma Biotechnology Inc   11.80 $ 37.906  Millions$ 3  Millions
Infusystem Holdings Inc  11.16 $ 35.271  Millions$ 3  Millions
Smiledirectclub Inc   10.81 $ 189.252  Millions$ 18  Millions
Scienture Holdings Inc   10.67 $ 2.763  Millions$ 0  Millions
Musclepharm Corporation  10.52 $ 66.546  Millions$ 6  Millions
Opko Health Inc   9.58 $ 504.190  Millions$ 53  Millions
Cryo cell International Inc   9.45 $ 10.073  Millions$ 1  Millions
Charles River Laboratories International inc   9.30 $ 1,427.723  Millions$ 154  Millions
Steris Plc  9.08 $ 1,710.972  Millions$ 188  Millions
Castle Biosciences Inc   8.47 $ 8.103  Millions$ 1  Millions
Perspective Therapeutics Inc   8.21 $ 4.393  Millions$ 1  Millions
Advanced Container Technologies Inc   7.98 $ 1.034  Millions$ 0  Millions
Caredx Inc   7.95 $ 48.114  Millions$ 6  Millions
Kewaunee Scientific Corporation  7.80 $ 124.113  Millions$ 16  Millions
Ufp Technologies Inc   7.56 $ 145.045  Millions$ 19  Millions
Catalent Inc   7.46 $ 1,967.200  Millions$ 264  Millions
Enzo Biochem Inc  7.13 $ 55.149  Millions$ 8  Millions
Fonar Corporation  6.97 $ 12.395  Millions$ 2  Millions
Omnova Solutions Inc  6.75 $ 548.400  Millions$ 81  Millions
Carlisle Companies Incorporated  6.66 $ 3,346.400  Millions$ 502  Millions
Twist Bioscience Corporation  6.62 $ 51.136  Millions$ 8  Millions
Nexgel Inc   6.61 $ 0.790  Millions$ 0  Millions
Align Technology inc   6.58 $ 672.631  Millions$ 102  Millions
Horizon Therapeutics Public Limited Company  6.42 $ 371.449  Millions$ 58  Millions
Dmk Pharmaceuticals Corporation  6.21 $ 15.540  Millions$ 3  Millions
Avid Bioservices Inc   6.15 $ 55.770  Millions$ 9  Millions

Date modified: 2026-08-29T17:23:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.